Athersys said its adult stem therapy for multiple sclerosis has produced lasting neurological improvements in recent animal studies and stopped the disease from progressing.
Scientists have long seen the potential of using induced pluripotent stem cells (iPSCs) to treat a variety of diseases and injuries. But previous researchers have linked the treatment to an increased cancer risk. And new research by University of California-Davis researchers identifies a possible reason why: That the cells are, in fact, similar to cancer.
Japanese scientists have found a way to spur transplanted pancreatic islet stem cells to differentiate into insulin-producing pancreatic cells. A mouse flu virus appeared to be the key to making this happen.
StemCells is getting $20 million from California's $3 billion stem cell funding initiative to advance the preclinical development of its Alzheimer's disease drug candidate. The goal: to move toward human trials within four years.
An ongoing focus in regenerative medicine is to figure out how pluripotent stem cells behave with both cell regeneration and disease. After all, they will be successful treatment tool only when researchers fully understand their modus operandi. A new study has uncovered some new clues, based on careful scrutiny of planarian worms.
There may be a better, more efficient way to trigger adult blood cells into becoming research- and patient-worthy stem cells.
Melanoma stem cells are marked by a particular enzyme that could serve as a potent new target for treatment, a University of Colorado Cancer Center study concludes.
The University of Cambridge in the U.K. is set to host the latest stem cell research institute, armed with more than $12.5 million in funding and a push to grow collaboration between academia, hospitals and industry.
Experimental stem cell treatments designed to treat Huntington's disease and spinal cord injuries are among projects set to get a piece of $150 million in new funding from the California Institute for Regenerative Medicine.
The cancer gene RhoC is directly connected to breast cancer stem cell metastasis, according to a new University of Michigan Comprehensive Cancer Center study published in PLoS One.